These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26147295)
21. Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. Bonfigli AR; Boemi M; Festa R; Bonazzi P; Brandoni G; Spazzafumo L; Olivieri F; Ceriello A; Genovese S; Testa R Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):893-8. PubMed ID: 27480449 [TBL] [Abstract][Full Text] [Related]
22. Two-week Triple Therapy with either Standard or High-dose Esomeprazole for First-line H. pylori Eradication. De Francesco V; Ridola L; Hassan C; Bellesia A; Alvaro D; Vaira D; Zullo A J Gastrointestin Liver Dis; 2016 Jun; 25(2):147-50. PubMed ID: 27308644 [TBL] [Abstract][Full Text] [Related]
24. Relationship between androgen deprivation therapy and community-acquired respiratory infections in patients with prostate cancer. Schmid M; Hanske J; Ravi P; Krishna N; Reznor G; Meyer CP; Fisch M; Noldus J; Nguyen PL; Trinh QD Int J Urol; 2016 Apr; 23(4):305-11. PubMed ID: 26763083 [TBL] [Abstract][Full Text] [Related]
25. Bifidobacterium animalis subsp. lactis in prevention of common infections in healthy children attending day care centers - Randomized, double blind, placebo-controlled study. Hojsak I; Močić Pavić A; Kos T; Dumančić J; Kolaček S Clin Nutr; 2016 Jun; 35(3):587-91. PubMed ID: 26031908 [TBL] [Abstract][Full Text] [Related]
26. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes. El Chaer F; Shah DP; Kmeid J; Ariza-Heredia EJ; Hosing CM; Mulanovich VE; Chemaly RF Cancer; 2017 Jun; 123(12):2329-2337. PubMed ID: 28178369 [TBL] [Abstract][Full Text] [Related]
27. Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults. Zirk-Sadowski J; Masoli JA; Delgado J; Hamilton W; Strain WD; Henley W; Melzer D; Ble A J Am Geriatr Soc; 2018 Jul; 66(7):1332-1338. PubMed ID: 29676433 [TBL] [Abstract][Full Text] [Related]
28. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study. Kiljander TO; Junghard O; Beckman O; Lind T Am J Respir Crit Care Med; 2010 May; 181(10):1042-8. PubMed ID: 20110554 [TBL] [Abstract][Full Text] [Related]
29. Analysis of 2-Week Data from Two Randomized, Controlled Trials Conducted in Subjects with Frequent Heartburn Treated with Esomeprazole 20 mg. Katz PO; Le Moigne A; Pollack C Clin Ther; 2017 May; 39(5):960-970. PubMed ID: 28431766 [TBL] [Abstract][Full Text] [Related]
30. The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover study. Shin JS; Lee JY; Cho KH; Park HL; Kukulka M; Wu JT; Kim DY; Park SH Aliment Pharmacol Ther; 2014 Sep; 40(5):548-61. PubMed ID: 25041486 [TBL] [Abstract][Full Text] [Related]
31. Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease. Gilger MA; Tolia V; Vandenplas Y; Youssef NN; Traxler B; Illueca M J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S16-23. PubMed ID: 26422093 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients. Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403 [TBL] [Abstract][Full Text] [Related]
33. Time-to-onset Analysis of Rhabdomyolysis due to Different Proton Pump Inhibitors Using a Pharmacovigilance Database. Ohyama K; Iida M; Akiyama S; Yamazaki H; Hori Y In Vivo; 2024; 38(3):1285-1291. PubMed ID: 38688634 [TBL] [Abstract][Full Text] [Related]
34. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial]. Geppe NA; Kondiurina EG; Galustian AN; Pak TE; Bal'tserovich NB; Zhiglinskaia OV; Kamaev AV; Lazareva SG; Laléko SL; Mel'nikova IM; Perminova OA; Sabitov AU Antibiot Khimioter; 2014; 59(5-6):6-14. PubMed ID: 25552038 [TBL] [Abstract][Full Text] [Related]
35. Acid-suppressive drugs and community-acquired pneumonia. Rodríguez LA; Ruigómez A; Wallander MA; Johansson S Epidemiology; 2009 Nov; 20(6):800-6. PubMed ID: 19797970 [TBL] [Abstract][Full Text] [Related]
37. [Incidence of community-acquired infections of lower airways among infants]. Martins AL; Nascimento Dda S; Schneider IJ; Schuelter-Trevisol F Rev Paul Pediatr; 2016 Jun; 34(2):204-9. PubMed ID: 26987781 [TBL] [Abstract][Full Text] [Related]
38. Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial. van Doorn L; Heersche N; de Man FM; de Bruijn P; Bijl I; Oomen-de Hoop E; Eskens FALM; van der Gaast A; Mathijssen RHJ; Bins S Clin Pharmacol Ther; 2022 Feb; 111(2):455-460. PubMed ID: 34656072 [TBL] [Abstract][Full Text] [Related]
39. Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study. McKeever T; Harrison TW; Hubbard R; Shaw D Chest; 2013 Dec; 144(6):1788-1794. PubMed ID: 23990003 [TBL] [Abstract][Full Text] [Related]
40. Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infection. Puig I; González-Santiago JM; Molina-Infante J; Barrio J; Herranz MT; Algaba A; Castro M; Gisbert JP; Calvet X Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28869699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]